Parkinson's Disease Clinical Trial
Official title:
A Randomized Controlled Pilot Trial Comparing Irish Set Dancing to Usual Care for People With Parkinson's Disease
Verified date | May 2016 |
Source | University of Limerick |
Contact | n/a |
Is FDA regulated | No |
Health authority | Ireland: Research Ethics Committee |
Study type | Interventional |
Primary aim is to conduct a pilot trial to determine:
1. The feasibility and efficiency of randomisation procedures and study design
2. If recruitment rates are sufficient to adequately power a larger trial
The secondary aim is to determine the efficiency of set dancing in comparison to a control
for people with Patkinson's disease.
Status | Completed |
Enrollment | 90 |
Est. completion date | January 2016 |
Est. primary completion date | January 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Have a diagnosis of idiopathic Parkinson's disease (Hackney et al 2007; Marchant et al 2010), stage 1-2.5 on the modified Hoeln and Yahr scale for staging of Parkinson's disease (Batson 2010) - Able to walk three meters with an assistive device - Over 18 years of age - Not pregnant - Have access to a computer/DVD player to allow them to participate in the home exercise programme Exclusion Criteria: - A serious cardiovascular and/or pulmonary condition (Lodder et al 2004) - A neurological deficit other than Parkinson's disease (Batson 2010; Marchant et al 2010) - Evidence of a musculoskeletal problem (Duncan and Earhart 2012), contraindicating participation in exercise participation(Lodder et al 2004) - A cognitive or hearing problem which will affect their ability to follow instructions or hear the music (Batson 2010) - Participated in regular dance classes in the past six months (Marchant et al 2010) |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Ireland | University of Limerick | Limerick | Munster |
Lead Sponsor | Collaborator |
---|---|
University of Limerick |
Ireland,
Duncan RP, Earhart GM. Randomized controlled trial of community-based dancing to modify disease progression in Parkinson disease. Neurorehabil Neural Repair. 2012 Feb;26(2):132-43. doi: 10.1177/1545968311421614. Epub 2011 Sep 29. — View Citation
Heiberger L, Maurer C, Amtage F, Mendez-Balbuena I, Schulte-Mönting J, Hepp-Reymond MC, Kristeva R. Impact of a weekly dance class on the functional mobility and on the quality of life of individuals with Parkinson's disease. Front Aging Neurosci. 2011 Oct 10;3:14. doi: 10.3389/fnagi.2011.00014. eCollection 2011. — View Citation
Marchant D, Sylvester JL, Earhart GM. Effects of a short duration, high dose contact improvisation dance workshop on Parkinson disease: a pilot study. Complement Ther Med. 2010 Oct;18(5):184-90. doi: 10.1016/j.ctim.2010.07.004. Epub 2010 Aug 21. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility of randomization procedures (To assess implementation of randomization procedures) | This outcome measure will be assessed over a 1 year period from study inception to completion | No | |
Primary | Attrition (To assess dropout rate during the study) | Attrition rate of = 20% per group will be deemed acceptable | This outcome measure will be assessed over a 1 year period from study inception to completion | No |
Primary | Intervention adherence (To assess compliance with the dance intervention) | 2) Intervention will be considered successful if no adverse effects or safety issues are reported and attendance at classes is =70% | This outcome will be assessed during the 10 week set dancing intervention | No |
Primary | Recruitment rates (To assess rate, duration and success of recruitment methods) | Recruitment considered successful and feasible is 100 participants are recruited in one year | This outcome will be assessed over a one year recruitment period | No |
Primary | Resources (To assess availability of personnel and building needed to implement study methodology) | Document issues regarding availability of personnel or buildings needed to implement study methodology | This outcome measure will be assessed over a 1 year period from study inception to completion | No |
Secondary | Exit Questionnaire (To assess participants satisfaction) | The exit questionnaire will assess participants' satisfaction with the dance intervention at the end of the study. The questionnaire asks participants if they have noted improvements in different aspects of physical well-being, and allows feedback relating to the structure, material and enjoyment of the dance classes to be gathered. This questionnaire has previously been used in other studies investigating the benefit of dance for those with Parkinson's disease (Hackney and Earhart 2009; Hackney and Earhart 2010). | This outcome will be assessed the week after the intervention period ends. | No |
Secondary | The Parkinson's Disease Questionnaire (PDQ-39) (To assess change in health related quality of life) | Self-report quality of life questionnaire | This outcome will be assessed within a week before the intervention begins and within a week after the intervention period ends | No |
Secondary | Unified Parkinson's Disease Rating Scale 3 (UPDRS-3) (To assess changes in motor impairment) | Disease specific measure of motor function | This outcome will be assessed within a week before the intervention begins and within a week after the intervention period ends | No |
Secondary | Six minute walk test (To assess change in functional endurnace) | Measure of functional endurance | This outcome will be assessed within a week before the intervention begins and within a week after the intervention period ends | No |
Secondary | MiniBESTest (To asses change in balance) | Balance measure | This outcome will be assessed within a week before the intervention begins and within a week after the intervention period ends | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Terminated |
NCT02894567 -
Evaluation of Directional Recording and Stimulation Using spiderSTN
|
N/A | |
Completed |
NCT02927691 -
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
|
Phase 2 |